Position in OCUL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$22,298,342
-$508,166 QoQ
Shares Held
2,270,707
-15.7% QoQ
Ownership
1.03%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#14
of 257 holders
Holding Since
Mar 2021
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OCUL Over Time
Shares Held
Position Value (USD)
Derivatives in OCUL
reported options exposure · as of Jun 30, 2026CallValue
$9,576,464
CallShares
975,200
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Balyasny Asset Management L.P. holds $2,350,910,046 across 177 Biotechnology names. OCUL ranks #35 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | APGE |
Apogee Therapeutics, Inc.
|
1,665,102 | $221,008,988 | |
| 2 | INSM |
INSMED Inc
|
1,326,430 | $141,423,966 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
1,230,052 | $91,614,272 | |
| 4 | ABVX |
Abivax S.A.
|
603,840 | $80,467,718 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
145,005 | $72,028,333 | |
| 6 | TNGX |
Tango Therapeutics, Inc.
|
2,016,379 | $63,032,007 | |
| 7 | CYTK |
Cytokinetics Inc
|
711,676 | $60,627,678 | |
| 8 | BMRN |
Biomarin Pharmaceutical Inc
|
1,054,613 | $60,344,955 |
All Filings in OCUL
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $22,298,342 | 2,270,707 | Shares | Sole | 2026-08-14 | |
| 2026-06-30 | $9,576,464 | 975,200 | Call | Sole | 2026-08-14 | |
| 2026-03-31 | $22,806,508 | 2,692,622 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $9,269,606 | 763,559 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $25,592,636 | 2,189,276 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $2,025,759 | 218,293 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $556,119 | 75,869 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $833,102 | 97,553 | Shares | Sole | 2025-02-14 | |
| 2023-12-31 | $396,940 | 89,000 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $164,360 | 52,344 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $249,135 | 48,282 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $84,920 | 16,114 | Shares | Other | 2023-05-15 | |
| 2022-12-31 | $70,224 | 24,991 | Shares | Sole | 2023-02-14 | |
| 2022-06-30 | $74,205 | 18,459 | Shares | Sole | 2022-08-15 | |
| 2021-12-31 | $76,056 | 10,912 | Shares | Sole | 2022-02-14 | |
| 2021-03-31 | $274,112 | 16,704 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||